Mycopreneur Sherry Rais: The Enthea Mission
5 snips
Dec 22, 2023 Sherry Rais, CEO of Enthea, discusses providing psychedelic-assisted therapy as a workplace benefit, global disparities in research, historical perspectives on psychedelics, various access models, and Enthea's expansion into psilocybin therapy.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 2min
Enhancing Workplace Wellbeing Through Ketamine Therapy
01:38 • 26min
Global Disparities and Inclusive Approach in Psychedelic Research
27:31 • 13min
Exploring Psychedelics: Cultural and Historical Perspectives
40:32 • 2min
Exploring Views on Psychedelics and Different Access Models
42:52 • 2min
Enthea's Progress and Expansion in Providing Psilocybin Therapy
45:08 • 3min
Optimism and Impact of Enthea's Mission in Psychedelic Therapy
48:02 • 4min